LifeMD, Inc. (LFMDP)
USD 22.12
(1.28%)
USD 22.12
(1.28%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 18.93 Million USD | 358.69% |
| 2022 | 4.12 Million USD | 123.18% |
| 2021 | 1.84 Million USD | 73.74% |
| 2020 | 1.06 Million USD | 26.01% |
| 2019 | 844.71 Thousand USD | 241.41% |
| 2018 | 247.41 Thousand USD | 47.73% |
| 2017 | 167.47 Thousand USD | -18.84% |
| 2016 | 206.36 Thousand USD | 106.37% |
| 2015 | 100 Thousand USD | 267.65% |
| 2014 | 27.2 Thousand USD | -32.34% |
| 2013 | 40.2 Thousand USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 262.17 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 20.81 Million USD | 4.58% |
| 2024 Q1 | 19.9 Million USD | 5.13% |
| 2023 Q1 | 16.47 Million USD | 299.16% |
| 2023 Q4 | 18.93 Million USD | -6.04% |
| 2023 Q2 | 15.3 Million USD | -7.08% |
| 2023 Q3 | 20.14 Million USD | 31.61% |
| 2023 FY | 18.93 Million USD | 358.69% |
| 2022 Q3 | 1.4 Million USD | -10.64% |
| 2022 Q2 | 1.57 Million USD | -12.66% |
| 2022 Q1 | 1.8 Million USD | -2.46% |
| 2022 FY | 4.12 Million USD | 123.18% |
| 2022 Q4 | 4.12 Million USD | 193.16% |
| 2021 FY | 1.84 Million USD | 73.74% |
| 2021 Q3 | 11.1 Million USD | 11.78% |
| 2021 Q4 | 1.84 Million USD | -83.34% |
| 2021 Q2 | 9.93 Million USD | 959.09% |
| 2021 Q1 | 937.67 Thousand USD | -11.91% |
| 2020 Q3 | 1.78 Million USD | 62.06% |
| 2020 FY | 1.06 Million USD | 26.01% |
| 2020 Q1 | 629.89 Thousand USD | -25.43% |
| 2020 Q2 | 1.09 Million USD | 74.61% |
| 2020 Q4 | 1.06 Million USD | -40.28% |
| 2019 Q2 | 300.38 Thousand USD | -34.6% |
| 2019 Q1 | 459.28 Thousand USD | 85.63% |
| 2019 Q4 | 844.71 Thousand USD | 12.24% |
| 2019 FY | 844.71 Thousand USD | 241.41% |
| 2019 Q3 | 752.62 Thousand USD | 150.55% |
| 2018 Q3 | - USD | -100.0% |
| 2018 FY | 247.41 Thousand USD | 47.73% |
| 2018 Q4 | 247.41 Thousand USD | 0.0% |
| 2018 Q2 | 63.09 Thousand USD | 0.0% |
| 2018 Q1 | - USD | -100.0% |
| 2017 Q1 | 25 Thousand USD | -87.89% |
| 2017 Q2 | 74.04 Thousand USD | 196.17% |
| 2017 Q3 | 77.33 Thousand USD | 4.44% |
| 2017 Q4 | 167.47 Thousand USD | 116.57% |
| 2017 FY | 167.47 Thousand USD | -18.84% |
| 2016 Q3 | 214.11 Thousand USD | 114.12% |
| 2016 FY | 206.36 Thousand USD | 106.37% |
| 2016 Q1 | 100 Thousand USD | 0.0% |
| 2016 Q2 | 100 Thousand USD | 0.0% |
| 2016 Q4 | 206.36 Thousand USD | -3.62% |
| 2015 Q2 | 98.48 Thousand USD | 7.12% |
| 2015 Q4 | 100 Thousand USD | -6.08% |
| 2015 Q3 | 106.47 Thousand USD | 8.11% |
| 2015 Q1 | 91.94 Thousand USD | 238.03% |
| 2015 FY | 100 Thousand USD | 267.65% |
| 2014 Q2 | 23.2 Thousand USD | -17.73% |
| 2014 Q1 | 28.2 Thousand USD | -29.85% |
| 2014 Q4 | 27.2 Thousand USD | -59.52% |
| 2014 Q3 | 67.2 Thousand USD | 189.66% |
| 2014 FY | 27.2 Thousand USD | -32.34% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | 40.2 Thousand USD | 0.0% |
| 2013 Q4 | 40.2 Thousand USD | 294.12% |
| 2013 Q3 | 10.2 Thousand USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | - USD | -100.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 FY | 262.17 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 1.32 Million USD | -1334.194% |
| BIMI International Medical Inc. | 5.45 Million USD | -247.042% |
| China Jo-Jo Drugstores, Inc. | 43.21 Million USD | 56.195% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 190.5 Million USD | 90.062% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 183.17 Million USD | 89.664% |
| Leafly Holdings, Inc. | 29.08 Million USD | 34.907% |
| Leafly Holdings, Inc. | 29.08 Million USD | 34.907% |
| LifeMD, Inc. | 18.93 Million USD | 0.0% |
| TRxADE HEALTH, Inc. | 7.1 Million USD | -166.506% |
| PetMed Express, Inc. | 1.45 Million USD | -1202.088% |
| Walgreens Boots Alliance, Inc. | 9.55 Billion USD | 99.802% |